DE60212842D1 - Dermatologische zusammensetzungen, die nikotinsäure oder nikotinsäureamid und sphingoid-base enthalten - Google Patents

Dermatologische zusammensetzungen, die nikotinsäure oder nikotinsäureamid und sphingoid-base enthalten

Info

Publication number
DE60212842D1
DE60212842D1 DE60212842T DE60212842T DE60212842D1 DE 60212842 D1 DE60212842 D1 DE 60212842D1 DE 60212842 T DE60212842 T DE 60212842T DE 60212842 T DE60212842 T DE 60212842T DE 60212842 D1 DE60212842 D1 DE 60212842D1
Authority
DE
Germany
Prior art keywords
nicotic acid
compositions containing
sphingoid base
nicotic
dermatological compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60212842T
Other languages
English (en)
Other versions
DE60212842T2 (de
Inventor
Jean-Claude Allart
Jean-Marie Lefevre
Jacques Peyrot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermaconcept JMC SARL
Original Assignee
Dermaconcept JMC SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8862592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60212842(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dermaconcept JMC SARL filed Critical Dermaconcept JMC SARL
Publication of DE60212842D1 publication Critical patent/DE60212842D1/de
Application granted granted Critical
Publication of DE60212842T2 publication Critical patent/DE60212842T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60212842T 2001-04-23 2002-04-17 Dermatologische zusammensetzungen, die nikotinsäure oder nikotinsäureamid und sphingoid-base enthalten Expired - Lifetime DE60212842T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0105451 2001-04-23
FR0105451A FR2823671B1 (fr) 2001-04-23 2001-04-23 Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoide
PCT/FR2002/001330 WO2002085362A2 (fr) 2001-04-23 2002-04-17 Composition dermatologique comprenant l'acide nicotinique ou un amide, et une base sphingoïde.

Publications (2)

Publication Number Publication Date
DE60212842D1 true DE60212842D1 (de) 2006-08-10
DE60212842T2 DE60212842T2 (de) 2007-06-28

Family

ID=8862592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212842T Expired - Lifetime DE60212842T2 (de) 2001-04-23 2002-04-17 Dermatologische zusammensetzungen, die nikotinsäure oder nikotinsäureamid und sphingoid-base enthalten

Country Status (17)

Country Link
US (1) US20040170591A1 (de)
EP (1) EP1404327B1 (de)
AT (1) ATE331516T1 (de)
AU (1) AU2002304546A1 (de)
BR (1) BR0205096A (de)
CA (1) CA2443939A1 (de)
CY (1) CY1106442T1 (de)
DE (1) DE60212842T2 (de)
DZ (1) DZ3504A1 (de)
ES (1) ES2263781T3 (de)
FR (1) FR2823671B1 (de)
IL (1) IL158455A0 (de)
MA (1) MA27014A1 (de)
PT (1) PT1404327E (de)
RU (1) RU2297224C2 (de)
TN (1) TNSN03102A1 (de)
WO (1) WO2002085362A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539125A4 (de) * 2002-08-14 2005-09-14 Kim Tae Yoon Zusammensetzung mit phytospingosin-derivaten zur einleitung von apoptose
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
DE102011109546A1 (de) * 2011-08-03 2013-02-07 Evonik Goldschmidt Gmbh Verwendung von Sphinganin zur Verbesserung des visuellen Erscheinungsbildes von Haut und Haar
EP3061501A1 (de) * 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
CN113546080A (zh) * 2020-04-08 2021-10-26 扬子江药业集团南京海陵药业有限公司 一种包含烟酰胺的药物组合物
CA3231023A1 (en) * 2021-09-15 2023-03-23 Nat Adkins Ointments for treating dry skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
JP3508042B2 (ja) * 1995-04-17 2004-03-22 カネボウ株式会社 セラミド合成促進剤
US5882665A (en) * 1997-11-18 1999-03-16 Elizabeth Arden Co., Division Of Conopco, Inc. Phytosphingosine salicylates in cosmetic compositions
DE19810999A1 (de) * 1998-03-13 1999-09-16 Dermapharm Gmbh Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten
CA2322586A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Moisturizing compositions
JP3884581B2 (ja) * 1998-10-05 2007-02-21 花王株式会社 ニキビ予防・改善剤
FR2868702B1 (fr) * 2004-04-09 2006-12-22 Negma Lerads Soc Par Actions S Utilisation d'une base sphingoide associee a l'acide nicotinique ou un amide de l'acide nicotinique a titre d'agent depigmentant

Also Published As

Publication number Publication date
TNSN03102A1 (fr) 2005-12-23
BR0205096A (pt) 2003-03-25
ATE331516T1 (de) 2006-07-15
ES2263781T3 (es) 2006-12-16
RU2297224C2 (ru) 2007-04-20
AU2002304546A1 (en) 2002-11-05
EP1404327B1 (de) 2006-06-28
WO2002085362A2 (fr) 2002-10-31
DZ3504A1 (fr) 2002-10-31
MA27014A1 (fr) 2004-12-20
EP1404327A2 (de) 2004-04-07
CA2443939A1 (fr) 2002-10-31
FR2823671A1 (fr) 2002-10-25
RU2003133986A (ru) 2005-03-10
FR2823671B1 (fr) 2004-01-09
US20040170591A1 (en) 2004-09-02
DE60212842T2 (de) 2007-06-28
WO2002085362A3 (fr) 2004-01-22
PT1404327E (pt) 2006-10-31
IL158455A0 (en) 2004-05-12
CY1106442T1 (el) 2011-10-12

Similar Documents

Publication Publication Date Title
ATE365703T1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate,deren herstellung und anwendungen
DE60329180D1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
BRPI0316438C1 (pt) uso de eritropoietina em doenças cardíacas
DE60212842D1 (de) Dermatologische zusammensetzungen, die nikotinsäure oder nikotinsäureamid und sphingoid-base enthalten
GEP20063955B (en) New process for the synthesis of (7-methoxy-3,4-dihydro-1-nap hthalenyl) acetonitrile and its application in the synthesis of agomelatine
WO2002040466A3 (en) Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
MY166631A (en) Orally administrable composition for improving skin quality
EP0699439A3 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
MY144055A (en) Orally administrable composition for improving hair and coat quality
MXPA05007771A (es) Procedimientos de tratamiento del dolor articular o para mejorar el sueno usando un agonista/antagonista de estrogeno.
DE60210101D1 (de) Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten
ZA200609220B (en) Method of treating dry eye disorders and uveitis
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
BRPI0416637A (pt) método para produção de uma solução aquosa de etanolamina de cobre e de uma solução de monoetanolamina de cobre
PL1635828T3 (pl) Pochodne 4-(2-fenyloksyfenylo)-piperydyny lub 1,2,3,6-tetrahydropirydyny jako inhibitory wychwytu zwrotnego serotoniny
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
WO2002060405A8 (en) Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
ATE509633T1 (de) Verwendung eines amid-derivats des ge 2270 faktors a3 für die behandlung von akne
RS50900B (sr) Postupak za pripremanje nevirapina
DK0627432T3 (da) 6-Piperazinyl-1H-pyrazolo(3,4-b)pyridin-3-carboxylsyrer, deres estere, amider og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE555783T1 (de) Mittel zur behandlung oder prävention von ischämischer neuropathie
ATE319503T1 (de) Regulierung des geruchs von kosmetischen zusammensetzungen, welche aminsalze enthalten
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
BRPI0417774A (pt) método para facilitar a aplicação de um artigo absorvente em um usuário, artigo correlacionado ao método e meio auxiliar de aplicação
UA11375U (uk) Спосіб електропунктурного дослідження точок голови при вертебрально-базилярних судинних порушеннях

Legal Events

Date Code Title Description
8364 No opposition during term of opposition